NOD2 deficiency protects against cardiac remodeling after myocardial infarction in mice

Cellular Physiology and Biochemistry

Volumn 32, Issue 6, 2013, Pages 1857-1866

  Li, Xiang ^a   Li, Fengli ^a   Chu, Yongli ^b   Wang, Xiaojie ^a   Zhang, Hongyu ^c   Hu, Yanyan ^c   Zhang, Yan ^a   Wang, Ziying ^a   Wei, Xinbing ^a   Jian, Wencheng ^c   Zhang, Xiumei ^a   Yi, Fan ^a  

^a SHANDONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b YANTAI YUHUANGDING HOSPITAL   (China)

^c SHANDONG UNIVERSITY   (China)

Author keywords

Cardiac dysfunction; Inflammation; Matrix metalloproteinase; NLR family

Indexed keywords

ALPHA SMOOTH MUSCLE ACTIN; CASPASE RECRUITMENT DOMAIN PROTEIN 15; GELATINASE B; INTERLEUKIN 1BETA; MITOGEN ACTIVATED PROTEIN KINASE P38; MONOCYTE CHEMOTACTIC PROTEIN 1; SHORT HAIRPIN RNA; TRANSFORMING GROWTH FACTOR BETA; TUMOR NECROSIS FACTOR ALPHA; MESSENGER RNA; MITOGEN ACTIVATED PROTEIN KINASE;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD VESSEL DIAMETER; CELL INFILTRATION; CELL ISOLATION; CONTROLLED STUDY; CORONARY ARTERY LIGATION; CYTOKINE PRODUCTION; ECHOCARDIOGRAPHY; ENZYME ACTIVITY; FIBROBLAST; GENE EXPRESSION; GENE SILENCING; HEART INFARCTION; HEART MUSCLE; HEART PROTECTION; HEART VENTRICLE WALL; HYPOXIA; INFLAMMATORY CELL; INNATE IMMUNITY; LEFT CORONARY ARTERY; MOUSE; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; REOXYGENATION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SIGNAL TRANSDUCTION; WESTERN BLOTTING; WILD TYPE; ADULT; ANIMAL TISSUE; HEART FUNCTION; HEART INJURY; HEART MUSCLE CELL; HEART VENTRICLE REMODELING; HEART VENTRICLE SIZE; IN VITRO STUDY; INFLAMMATION; PROTEIN FUNCTION;

MUS;

ANIMALS; CELL HYPOXIA; CELLS, CULTURED; CYTOKINES; DISEASE MODELS, ANIMAL; ECHOCARDIOGRAPHY; FIBROBLASTS; MAP KINASE SIGNALING SYSTEM; MATRIX METALLOPROTEINASE 9; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; MYOCARDIAL INFARCTION; MYOCARDIUM; NOD2 SIGNALING ADAPTOR PROTEIN; RNA INTERFERENCE; RNA, MESSENGER; RNA, SMALL INTERFERING; VENTRICULAR REMODELING;

EID: 84890463354     PISSN: 10158987     EISSN: 14219778     Source Type: Journal    
DOI: 10.1159/000356618     Document Type: Article

References (36)

1. Frangogiannis NG: Regulation of the inflammatory response in cardiac repair. Circ Res 2012;110:159-173.
2. Hori M, Nishida K: Toll-like receptor signaling: Defensive or offensive for the heart? Circ Res 2008;102:137-139.
3. Liaudet L, Rosenblatt-Velin N: Role of innate immunity in cardiac inflammation after myocardial infarction. Front Biosci 2013;5:86-104.
4. Arslan F, de Kleijn DP, Pasterkamp G: Innate immune signaling in cardiac ischemia. Nat Rev Cardiol 2011;8:292-300.
5. Chao W: Toll-like receptor signaling: A critical modulator of cell survival and ischemic injury in the heart. Am J Physiol Heart Circ Physiol 2009;296:H1-12.
6. Libby P, Ridker PM, Hansson GK, Leducq Transatlantic Network on A: Inflammation in atherosclerosis: From pathophysiology to practice. J Am Coll Cardiol 2009;54:2129-2138.
7. Timmers L, Sluijter JP, van Keulen JK, Hoefer IE, Nederhoff MG, Goumans MJ, Doevendans PA, van Echteld CJ, Joles JA, Quax PH, Piek JJ, Pasterkamp G, de Kleijn DP: Toll-like receptor 4 mediates maladaptive left ventricular remodeling and impairs cardiac function after myocardial infarction. Circ Res 2008;102:257-264.
8. Schroder K, Tschopp J: The inflammasomes. Cell 2010;140:821-832.
9. Ting JP, Duncan JA, Lei Y: How the noninflammasome NLRs function in the innate immune system. Science 2010;327:286-290.
10. Magalhaes JG, Sorbara MT, Girardin SE, Philpott DJ: What is new with NODs? Curr Opin Immunol 2011;23:29-34.
11. Du P, Fan B, Han H, Zhen J, Shang J, Wang X, Li X, Shi W, Tang W, Bao C, Wang Z, Zhang Y, Zhang B, Wei X, Yi F: NOD2 promotes renal injury by exacerbating inflammation and podocyte insulin resistance in diabetic nephropathy. Kidney Int 2013;84:265-276.
12. Han H, Wang Y, Li X, Wang PA, Wei X, Liang W, Ding G, Yu X, Bao C, Zhang Y, Wang Z, Yi F: Novel role of NOD2 in mediating Ca2+ signaling: Evidence from NOD2-regulated podocyte TRPC6 channels in hyperhomocysteinemia. Hypertension 2013;62:506-511.
13. Kwon MY, Liu X, Lee SJ, Kang YH, Choi AM, Lee KU, Perrella MA, Chung SW: Nucleotide-binding oligomerization domain protein 2 deficiency enhances neointimal formation in response to vascular injury. Arterioscler Thromb Vasc Biol 2011;31:2441-2447.
14. Shigeoka AA, Kambo A, Mathison JC, King AJ, Hall WF, da Silva Correia J, Ulevitch RJ, McKay DB: Nod1 and Nod2 are expressed in human and murine renal tubular epithelial cells and participate in renal ischemia reperfusion injury. J Immunol 2010;184:2297-2304.
15. Li J, Zhang Y, Li C, Xie J, Liu Y, Zhu W, Zhang X, Jiang S, Liu L, Ding Z: HSPA12B attenuates cardiac dysfunction and remodelling after myocardial infarction through an enos-dependent mechanism. Cardiovasc Res 2013;99:674-684.
16. Ti Y, Hao MX, Li CB, Wang ZH, Hou XY, Zhao XQ, Liu JN, Zhang W, Zhang Y, Bu PL: Rosiglitazone attenuates myocardial remodeling in spontaneously hypertensive rats. Hypertens Res 2011;34:354-360.
17. Sandanger O, Ranheim T, Vinge LE, Bliksoen M, Alfsnes K, Finsen AV, Dahl CP, Askevold ET, Florholmen G, Christensen G, Fitzgerald KA, Lien E, Valen G, Espevik T, Aukrust P, Yndestad A: The NLRP3 inflammasome is up-regulated in cardiac fibroblasts and mediates myocardial ischaemia-reperfusion injury. Cardiovasc Res 2013;99:164-174.
18. Zhang Y, Wei X, Liu L, Liu S, Wang Z, Zhang B, Fan B, Yang F, Huang S, Jiang F, Chen YH, Yi F: TIPE2, a novel regulator of immunity, protects against experimental stroke. J Biol Chem 2012;287:32546-32555.
19. Wang Z, Wei X, Zhang Y, Ma X, Li B, Zhang S, Du P, Zhang X, Yi F: NADPH oxidase-derived ROS contributes to upregulation of TRPC6 expression in puromycin aminonucleoside-induced podocyte injury. Cell Physiol Biochem 2009;24:619-626.
20. Yi F, Zhang AY, Janscha JL, Li PL, Zou AP: Homocysteine activates NADH/NADPH oxidase through ceramide-stimulated Rac GTPase activity in rat mesangial cells. Kidney Int 2004;66:1977-1987.
21. Wang Z, Tsai LK, Munasinghe J, Leng Y, Fessler EB, Chibane F, Leeds P, Chuang DM: Chronic valproate treatment enhances postischemic angiogenesis and promotes functional recovery in a rat model of ischemic stroke. Stroke 2012;43:2430-2436.
22. Wang Z, Wei X, Liu K, Zhang XM, Zhang H, He YT, Zhu T, LI F, Shi W, Zhang Y, Yi F: NOX2 Deficiency Ameliorates Cerebral Injury by Reduction of Complexin II-mediated Glutamate Excitotoxicity in Experimental Stroke. Free Radic Biol Med 2013;24:65C:942-951.
23. Frantz S, Ertl G, Bauersachs J: Mechanisms of disease: Toll-like receptors in cardiovascular disease. Nat Clin Pract Cardiovasc Med 2007;4:444-454.
24. Duewell P, Kono H, Rayner KJ, Sirois CM, Vladimer G, Bauernfeind FG, Abela GS, Franchi L, Nunez G, Schnurr M, Espevik T, Lien E, Fitzgerald KA, Rock KL, Moore KJ, Wright SD, Hornung V, Latz E: NLRP3 inflammasomes are required for atherogenesis and activated by cholesterol crystals. Nature 2010;464:1357-1361.
25. Nishio H, Kanno S, Onoyama S, Ikeda K, Tanaka T, Kusuhara K, Fujimoto Y, Fukase K, Sueishi K, Hara T: Nod1 ligands induce site-specific vascular inflammation. Arterioscler Thromb Vasc Biol 2011;31:1093-1099.
26. Fernandez-Velasco M, Prieto P, Terron V, Benito G, Flores JM, Delgado C, Zaragoza C, Lavin B, Gomez- Parrizas M, Lopez-Collazo E, Martin-Sanz P, Bosca L: NOD1 activation induces cardiac dysfunction and modulates cardiac fibrosis and cardiomyocyte apoptosis. PloS one 2012;7:e45260.
27. Spinale FG, Janicki JS, Zile MR: Membrane-associated matrix proteolysis and heart failure. Circ Res 2013;112:195-208.
28. Chapman RE, Scott AA, Deschamps AM, Lowry AS, Stroud RE, Ikonomidis JS, Spinale FG: Matrix metalloproteinase abundance in human myocardial fibroblasts: Effects of sustained pharmacologic matrix metalloproteinase inhibition. J Mol Cell Cardiol 2003;35:539-548.
29. Halade GV, Jin YF, Lindsey ML: Matrix metalloproteinase (MMP)-9: A proximal biomarker for cardiac remodeling and a distal biomarker for inflammation. Pharmacol Ther 2013;139:32-40.
30. Konstantino Y, Nguyen TT, Wolk R, Aiello RJ, Terra SG, Fryburg DA: Potential implications of matrix metalloproteinase-9 in assessment and treatment of coronary artery disease. Biomarkers 2009;14:118-129.
31. Bradley LM, Douglass MF, Chatterjee D, Akira S, Baaten BJ: Matrix metalloprotease 9 mediates neutrophil migration into the airways in response to influenza virus-induced toll-like receptor signaling. PLoS Pathog 2012;8:e1002641.
32. Jackson L, Cady CT, Cambier JC: TLR4-mediated signaling induces MMP9-dependent cleavage of b cell surface cd23. J Immunol 2009;183:2585-2592.
33. Ospelt C, Brentano F, Jungel A, Rengel Y, Kolling C, Michel BA, Gay RE, Gay S: Expression, regulation, and signaling of the pattern-recognition receptor nucleotide-binding oligomerization domain 2 in rheumatoid arthritis synovial fibroblasts. Arthritis Rheum 2009;60:355-363.
34. Frangogiannis NG, Smith CW, Entman ML: The inflammatory response in myocardial infarction. Cardiovasc Res 2002;53:31-47.
35. Lim AK, Tesch GH: Inflammation in diabetic nephropathy. Mediators Inflamm 2012;2012:146154.
36. Zong J, Salim M, Zhou H, Bian ZY, Dai J, Yuan Y, Deng W, Zhang JY, Zhang R, Wu QQ, Tang QZ: NOD2 deletion promotes cardiac hypertrophy and fibrosis induced by pressure overload. Lab Invest 2013;93:1128-1136.